Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 2:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Cognitive Impairment, Executive Dysfunction, Acquired Brain Injury
Interventions: Multicontext (MC) approach; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Patulous Eustachian Tube Dysfunction, Eustachian Tube Dysfunction
Interventions: Internal nasal dilator; Device
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment
Interventions: Placebo, EG-501; Drug
Lead sponsor: Evergreen Therapeutics, Inc.; Industry
Eligibility: 18 Years to 69 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 3
States / cities: Cleveland, Ohio • Nashville, Tennessee • Houston, Texas

Conditions: Mild Cognitive Impairment (MCI)
Interventions: Gamma- Glutamylcysteine, Gamma- Glutamylcusteine; Drug
Lead sponsor: Pravat Mandal; Other
Eligibility: 55 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alcohol Use Disorder, Mild Cognitive Impairment
Interventions: Donepazil; Combination Product
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 21 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Dementia, Alzheimer Disease (AD), Depression Chronic, Caregiver Burden of People With Dementia, Cognitive Impairments
Interventions: Receptive Music Therapy; Behavioral
Lead sponsor: Florida SouthWestern State College; Other
Eligibility: 25 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Dementia, Mild, Mild Cognitive Impairment (MCI)
Interventions: Let's Talk Tech; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Functional Disorder of Intestine, Nausea Persistent
Interventions: Neurostimulator, Sham; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 11 Years to 18 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: End Stage Renal Disease, Sexual Dysfunction, Physiological, Pain, Depression
Interventions: Symptom management nurse intervention, Feedback intervention; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Vertigo, Dizziness, Benign Paroxysmal Positional Vertigo, Labyrinthitis
Interventions: Osteopathic Manipulative Treatment (OMT), Vestibular Rehabilitation Therapy (VRT); Other
Lead sponsor: Western University of Health Sciences; Other
Eligibility: 18 Years to 79 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Pomona, California

Conditions: Erectile Dysfunction
Interventions: WC3036-11F/Alprostadil in Vehicle 2.5%, WC3036-12F/Alprostadil in Vehicle 0.5%, WC3036-13P/Vehicle Only 0.5%; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Purchase, New York

Conditions: Menopause, Vulvovaginal Atrophy, Painful Intercourse, Dyspareunia
Interventions: Estradiol, placebo; Drug
Lead sponsor: TherapeuticsMD; Industry
Eligibility: 40 Years to 75 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: DeLand, Florida

Conditions: Gestational Diabetes Mellitus, Pregnancy
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chemotherapy-related Cognitive Dysfunction
Interventions: Memory and Attention Adaptation Training (MAAT), Supportive Therapy (ST); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Indianapolis, Indiana • Pittsburgh, Pennsylvania

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo, Sildenafil, Testosterone; Drug
Lead sponsor: Emotional Brain NY Inc.; Industry
Eligibility: 21 Years to 70 Years · Female only
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 14
States / cities: San Diego, California • Washington D.C., District of Columbia • Brooksville, Florida + 11 more

Conditions: Ischemic Heart Disease, Myocardial Ischemia
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Gestational Diabetes, Vascular Endothelial Function
Interventions: Acetylcholine, insulin aspart; Drug
Lead sponsor: Anna Stanhewicz, PhD; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Cognitive Impairment
Interventions: Not listed
Lead sponsor: GE Healthcare; Industry
Eligibility: 55 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Alzheimer's Disease
Interventions: Resonator, Placebo; Device
Lead sponsor: pico-tesla Magnetic Therapies, LLC; Industry
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Denver, Colorado • Clearwater, Florida

Conditions: Orofacial Myofunctional Disorders, Myo Munchee, Oral Motor Therapy, Maxillary Deficiency
Interventions: Chewing device only, Myo Munchee and Oral Motor Therapy Treatment, Oral Motor Therapy Treatment Arm; Device · Other
Lead sponsor: Myo Munchee (Operations) Pty Ltd; Industry
Eligibility: 3 Years to 5 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Vestibular Disorder, Fall, Coordination and Balance Disturbances
Interventions: Vestibular Rehabilitation; Other
Lead sponsor: Methodist University, North Carolina; Other
Eligibility: Female only
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Fayetteville, North Carolina

Conditions: Hydrocephalus
Interventions: Not listed
Lead sponsor: Transonic Systems Inc.; Industry
Eligibility: Up to 20 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection
Interventions: Pirfenidone; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Bradycardia, Sinus Node Dysfunction
Interventions: MRI, ImageReady System implant; Radiation · Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 29
States / cities: Mesa, Arizona • Los Angeles, California • San Francisco, California + 26 more

Search by objective public record fields.

Case Studies: Promoting Strategy Use in Functional Activities

Nasal Dilator Therapy for Patulous Eustachian Tube Dysfunction

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder

Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Efficacy of Ear Neurostimulation for Adolescents With Functional Abdominal Pain

Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients

Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction

Telehealth and Memory Study

Lybrido for Female Sexual Dysfunction

Quality of Life in Patients With Chronic Ischemic Heart Disease

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem

Study of Magnetic Fields to Treat Alzheimer's Disease

Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).

Vestibular Rehabilitation for Chronic Central Vestibular Deficits: A Case Study

Diagnosing Malfunctioning Hydrocephalic Shunt Valves With a Flow Sensor

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

ImageReady(TM) MR Conditional Pacing System Clinical Study